Cochran D P, Shaw N J
Neonatal Intensive Care Unit, Fazakerley Hospital, Liverpool, UK.
Eur J Pediatr. 1995 Mar;154(3):222-4. doi: 10.1007/BF01954276.
When deciding an appropriate upper limit for pulse oxygen saturation (SpO2) in preterm infants the usefulness of current data is limited by the fact that previous studies have examined a population of more mature infants and children or have applied various exclusion criteria which produce results unrepresentative of clinical practice. We tested the hypothesis of previous workers that maintaining the SpO2 below 98% would ensure an arterial oxygen tension (PaO2) less than 12kPa. A total of 477 simultaneous measurements of PaO2 and SpO2 were made using Ohmeda Biox oximeters on 43 infants who were less than 33 weeks gestation and receiving supplementary oxygen. Of 435 measurements performed when the SpO2 was 97% or less, 26 (6%) had a PaO2 greater than 12kPa. Further examination of the data showed that of 108 estimations performed when the SpO2 was less than 94%, none had a PaO2 greater than 12kPa.
When using Ohmeda Biox pulse oximeters an upper limit of 97% for SaO2 is not effective in preventing hyperoxaemia; however, a limit of 93% is likely to maintain the PaO2 below 12kPa.
在确定早产儿脉搏血氧饱和度(SpO2)的合适上限时,当前数据的实用性受到限制,因为先前的研究考察的是更成熟的婴儿和儿童群体,或者应用了各种排除标准,从而得出了不能代表临床实践的结果。我们检验了先前研究者的假设,即维持SpO2低于98%可确保动脉血氧分压(PaO2)低于12kPa。使用欧姆龙Biox血氧饱和度仪对43名孕周小于33周且正在接受补充氧气的婴儿同时进行了477次PaO2和SpO2测量。在SpO2为97%或更低时进行的435次测量中,有26次(6%)的PaO2大于12kPa。对数据的进一步检查显示,在SpO2小于94%时进行的108次测量中,没有一次PaO2大于12kPa。
使用欧姆龙Biox脉搏血氧饱和度仪时,将SaO2上限设定为97%并不能有效预防高氧血症;然而,将上限设定为93%可能会使PaO2维持在12kPa以下。